By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Azaya Therapeutics, Inc. 

12500 Network Boulevard

San Antonio  Texas  78249  U.S.A.
Phone: 210-341-6600 Fax: 210-341-6619




Company News
Cytori (CYTX) Restarting Texas Facility it Inherited From Azaya Therapeutics Buyout Deal 5/4/2017 6:09:52 AM
Cytori (CYTX) Release: San Diego Biotech Scoops Up Azaya Therapeutics in Deal Worth $170 Million 1/20/2017 5:35:05 AM
Azaya Therapeutics, Inc. Collaborates With University of Chicago In Combination Study In Animals 5/6/2014 10:21:12 AM
CANbridge Life Sciences Enters Into Agreement With Azaya Therapeutics, Inc. to Develop ATI-1123 for Lung Cancer in China and North Asia 9/11/2013 9:44:19 AM
Azaya Therapeutics, Inc. Launches Parexo Labs, Offering Liposomal Manufacture and Nanotechnology Testing Services to Drug and Device Developers 7/8/2013 10:22:44 AM
Azaya Therapeutics, Inc. Initiates Bioequivalency Study for Regulatory Approval of ATI-0918, a Liposomal Formulation of Doxorubicin Hydrochloride 10/24/2012 9:39:22 AM
Azaya Therapeutics, Inc. Reports Results of Phase I Clinical Trial 6/13/2012 10:05:23 AM
ResearchPoint & Azaya Therapeutics, Inc. Announce First Patient Enrolled in Phase I Clinical Study 1/26/2010 9:35:50 AM
SATAI Announces $1.045 Million Emerging Technology Fund Investment in Azaya Therapeutics, Inc. 9/30/2009 9:26:01 AM
Azaya Therapeutics, Inc. Initiates Collaboration With National Cancer Institute in Nanoparticle Characterization 3/10/2009 8:51:07 AM